Bimekizumab has shown durable long-term clearance of psoriasis in patients. Reports indicate that the treatment achieves high rates of complete skin clearance, with some patients maintaining clearance for up to four years. However, there is also mention of a different treatment, icotrokinra, maintaining psoriasis skin clearance, suggesting that bimekizumab may not be the only treatment with this effect.